2020 Global life sciences outlook
Creating new value | Building blocks for the future
Gene therapies, intelligent drug discovery and development, consumer wearables, telemedicine, and more—what are some of the drivers transforming the life sciences sector? How can biopharma and medtech organizations create new value in 2020, while tackling various challenges?
Winning in the future of medtech
How consumer tech partnerships can lead to success in a transforming industry
Medtech companies are well-positioned to drive the future of health, but most cannot do it alone. They should instead partner with consumer technology and specialized digital health companies to meet the changing market.
Platforms and Ecosystems
Enabling the Digital Economy
This whitepaper, part of the World Economic Forum's "Shaping the Future of the Digital Economy and Society initiative," looks at six key dimensions that determine whether digital platforms can retain public trust and governance and how they can revamp public-private collaboration for the same.
FT Global Pharma & Biotechnology Conference 2019
Embracing the future of work to unlock R&D productivity
Measuring the return from pharmaceutical innovation 2018
The biopharma industry continues to face challenges this year, with projected returns on investment in R&D at the lowest levels since our analysis began in 2010. Can this trend be reversed?
Medtech and the Internet of Medical Things
How connected medical devices are transforming health care
New research from Deloitte UK Centre for Health Solutions examines how the IoMT is transforming medtech’s role in health care. It outlines how medtech companies can get digital transformation right – whether through adapting their existing business models, inventing new ones or both.
The digital hospital of the future
In 10 years, technology may change the face of global health care delivery
Learn how the digital hospital of the future can leverage technology to transform the future of health care delivery, including digital patient experience in this report developed by Deloitte US.
How do health care consumers and doctors perceive virtual care?
Our 2018 survey results show an interesting juxtaposition
Virtual health care is popular—in theory. Deloitte surveys of US physicians and health care consumers found support for the concept, but doctors aren’t meeting demand. However, organizations that get on board sooner rather than later may see the benefits.
Future of business interaction
A study on the interaction between MedTech companies and hospitals
With this study, we shine a spotlight on the challenges in business interactions today. We aim to drive forward the discussion among stakeholders so as to find solutions that can be applied broadly, yielding benefits for all parties involved.
EU Clinical Trial Regulation
Building a successful program
The implementation of the new European Union (EU) Clinical Trial Regulation will provide a unified portal and database for trial sponsors and regulatory agencies across the EU Member States, promising to bring greater regulatory convergence and efficiency to the clinical trial application process.
The future awakens
Life Sciences and Health Care Predictions 2022
The year is 2022. The quantified self is alive and well, digital technologies have transformed the culture of health care and new entrants have disrupted delivery models. These are some of our predictions that, if they come true, will shake up the life sciences and health care industry.
Time to care
Securing a future for the hospital workforce in Europe
In light of rising demand, staff shortages and lack of time for hands-on-care, is the current hospital workforce model sustainable? New research released by the Deloitte UK Centre for Health Solutions explores the current state of hospital workforces across Europe and their key challenges.
Pharma and the connected patient
How digital technology is enabling patient centricity
New research released by the Deloitte UK Centre for Health Solutions explores how digital technology can help pharma embrace patient centricity to remain relevant, profitable, and to deliver better health outcomes.